Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.
Reset all filters
01 1Transo-Pharm Handels GmbH
02 1Transo-Pharm USA LLC
03 1LGM Pharma
04 1TAPI Technology & API Services
05 1Concord Biotech
06 1Exopharm
07 1Jiwan Pharmaceutical Technology Co., Ltd
08 1Olon S.p.A
09 1Pfizer Inc
10 1Sicor Spa
11 2Synbias Pharma Limited Liability Company
12 1Tecoland Corporation
13 1Teva Pharmaceutical Industries
14 1Zhejiang Hisun Pharmaceutical
Reset all filters
01 1Australia
02 2China
03 1Germany
04 1India
05 2Israel
06 2Italy
07 4U.S.A
08 2Ukraine
Reset all filters
01 3Active
02 4Inactive
03 8Blank
01 15Blank
Reset all filters
01 15Blank
Reset all filters
01 15Blank
Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
GDUFA
DMF Review : Reviewed
Rev. Date : 2012-11-29
Pay. Date : 2012-11-08
DMF Number : 13884
Submission : 1998-12-07
Status : Active
Type : II
Available Reg Filing : CA, ASMF |
GDUFA
DMF Review : Reviewed
Rev. Date : 2022-06-15
Pay. Date : 2022-05-31
DMF Number : 36526
Submission : 2021-12-02
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-01-22
Pay. Date : 2013-11-26
DMF Number : 19613
Submission : 2006-07-17
Status : Active
Type : II
NDC Package Code : 58623-0027
Start Marketing Date : 2019-08-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17504
Submission : 2004-06-26
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19185
Submission : 2006-02-08
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13876
Submission : 1998-12-04
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16057
Submission : 2002-07-18
Status : Inactive
Type : II
NDC Package Code : 17337-0098
Start Marketing Date : 2021-06-14
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Idarubicin Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Idarubicin Hydrochloride, including repackagers and relabelers. The FDA regulates Idarubicin Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Idarubicin Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Idarubicin Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Idarubicin Hydrochloride supplier is an individual or a company that provides Idarubicin Hydrochloride active pharmaceutical ingredient (API) or Idarubicin Hydrochloride finished formulations upon request. The Idarubicin Hydrochloride suppliers may include Idarubicin Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Idarubicin Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
We have 14 companies offering Idarubicin Hydrochloride
Get in contact with the supplier of your choice: